Evidence map›Paper›PMID 36820095›Full record

ArticleACS nanoscience Au2023

Robust Nanoparticle-Derived Lubricious Antibiofilm Coating for Difficult-to-Coat Medical Devices with Intricate Geometry.

Hossein Yazdani-Ahmadabadi, Kai Yu, Sara Khoddami, Demian F Felix, Han H Yeh, Haiming D Luo, Igor Moskalev, Qiong Wang, Rizhi Wang, Dana Grecov and 3 more

Open access · goldAbstract read
In one paragraph

Article in ACS nanoscience Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Hossein Yazdani-AhmadabadiDepartment of Chemistry, University of British Columbia, Vancouver V6T 1Z3, British Columbia, Canada.
Kai YuCentre for Blood Research, Life Science Institute, University of British Columbia, Vancouver V6T 1Z3, British Columbia, Canada.
Sara KhoddamiDepartment of Urologic Sciences, University of British Columbia, Vancouver V6H 3Z6, British Columbia, Canada.
Demian F FelixDepartment of Urologic Sciences, University of British Columbia, Vancouver V6H 3Z6, British Columbia, Canada.
Han H YehDepartment of Mechanical Engineering, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.
Haiming D LuoDepartment of Chemistry, University of British Columbia, Vancouver V6T 1Z3, British Columbia, Canada.
Igor MoskalevVancouver Prostate Centre, University of British Columbia, Vancouver V6H 3Z6, British Columbia, Canada.
Qiong WangDepartment of Materials Engineering, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.
Rizhi WangDepartment of Materials Engineering, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.
Dana GrecovDepartment of Mechanical Engineering, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada.
Ladan FazliVancouver Prostate Centre, University of British Columbia, Vancouver V6H 3Z6, British Columbia, Canada.
Dirk LangeDepartment of Urologic Sciences, University of British Columbia, Vancouver V6H 3Z6, British Columbia, Canada.
Jayachandran N KizhakkedathuDepartment of Chemistry, University of British Columbia, Vancouver V6T 1Z3, British Columbia, Canada.ORCID https://orcid.org/0000-0001-7688-7574
University of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major medical device-associated complication is the biofilm-related infection post-implantation. One promising approach to prevent this is to coat already commercialized medical devices with effective antibiofilm materials. However, developing a robust high-performance antibiofilm coating on devices with a nonflat geometry remains unmet. Here, we report the development of a facile scalable nanoparticle-based antibiofilm silver composite coating with long-term activity applicable to virtually any objects including difficult-to-coat commercially available medical devices utilizing a catecholic organic-aqueous mixture. Using a screening approach, we have identified a combination of the organic-aqueous buffer mixture which alters polycatecholamine synthesis, nanoparticle formation, and stabilization, resulting in controlled deposition of in situ formed composite silver nanoparticles in the presence of an ultra-high-molecular-weight hydrophilic polymer on diverse objects irrespective of its geometry and chemistry. Methanol-mediated synthesis of polymer-silver composite nanoparticles resulted in a biocompatible lubricious coating with high mechanical durability, long-term silver release (∼90 days), complete inhibition of bacterial adhesion, and excellent killing activity against a diverse range of bacteria over the long term. Coated catheters retained their excellent activity even after exposure to harsh mechanical challenges (rubbing, twisting, and stretching) and storage conditions (>3 months stirring in water). We confirmed its excellent bacteria-killing efficacy (>99.999%) against difficult-to-kill bacteria (

Identifiers

PMID36820095
PMCPMC9936578
OpenAlexW4307482831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.